Diego Based Dexcom News Today

Dexcom announced that it submitted its new Stelo glucose sensor to the FDA for review at the end of last year.

Dexcom (Nasdaq:DXCM) today unveiled its strategy to expand access to its glucose-sensing technology for millions around the world.

Dexcom (Nasdaq:DXCM) today announced that it intends to offer $1 billion in convertible senior notes due in 2028.

Dexcom announced today that Medicare offers coverage for its beneficiaries using the next-generation G7 CGM.

Dexcom (Nasdaq:DXCM) announced today that the FDA cleared the next-generation Dexcom G7 continuous glucose monitoring (CGM) system.

Major players in the diabetes space could join forces as Dexcom (Nasdaq:DXCM) is reportedly in discussions to acquire Insulet (Nasdaq:PODD).

Dexcom (Nasdaq:DXCM) announced today that its board of directors approved a four-for-one forward split of the company’s common stock.

An Abbott Laboratories subsidiary focused on diabetes care sued rival DexCom in Delaware federal court for allegedly violating a 2014 settlement agreement and asked the court to declare that Abbott doesn't infringe its patents.

MedCity News Abbott gets FDA clearance for CGM app Abbott received FDA clearance for an app to pair with its Freestyle Libre 2 glucose monitor. The app lets people get readings directly on their phone without using a reader. Shares0 The iPhone app would let people get glucose readings directly on their phone without using a reader. Users can scan a sensor built into the Freestyle Libre 2 to get their current glucose reading and trends. They can also share glucose readings and real-time alarm...

San Diego-based Dexcom, which develops equipment for continuous glucose monitoring for people with diabetes, has launched its own venture capital fund, Dexcom Ventures. According to Dexcom, the new fu